| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 4.22 Billion |
| Market Size (2030) | USD 5.68 Billion |
| CAGR (2025 - 2030) | 6.10 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Europe Advanced Wound Care Market Analysis
The Europe Advanced Wound Care Market size is estimated at USD 4.22 billion in 2025, and is expected to reach USD 5.68 billion by 2030, at a CAGR of 6.1% during the forecast period (2025-2030).
The major factors expected to drive the growth of the European advanced wound care market include the high and increasing burden of chronic diseases such as diabetes, a rising number of surgeries, and an increasing geriatric population, among other risk factors. Lower limb ulceration causes significant patient distress and exerts considerable pressure on the healthcare service in the region.
Notably, venous leg ulcers (VLUs) are the most common hard-to-heal wounds in the United Kingdom. For instance, according to data from the Integrated Care Journal published in September 2023, more than a million people in the United Kingdom are affected by lower limb ulcers, with around 560,000 classified as VLUs. This high prevalence underscores the rising demand for advanced wound care products in the United Kingdom, fueling market growth over the study period.
In addition, according to the International Diabetes Federation (IDF) 2024, the prevalence of diabetes in adults aged 20-79 years in Europe is estimated to be 67 million by 2030 and 69 million by 2045. The increasing prevalence of diabetes likely increases the risk of diabetic foot ulcers and is expected to create demand for advanced wound care and related products. Hence, the high and growing burden of ulcers and diabetic patients in European countries is expected to create demand for advanced wound care products and fuel the market growth over the forecast period.
Furthermore, the increasing investments in the development of advanced wound care products in Europe are expected to augment the growth of the studied market. For instance, in August 2024, the research team from the University of Manchester received funding of USD 2.21 million to develop an innovative wound dressing that aims to prevent infections and enhance the healing process. Therefore, such investments in the development of innovative wound care products are likely to boost the studied market growth over the forecast period.
Therefore, owing to the above-mentioned factors, such as the high burden of venuos leg ulcers, diabetes, and rising investments for the development of innovative wound care products, are likely to contribute to the studied market growth. However, the high cost associated with the treatment and reimbursement issues for the new technologies is the primary factor expected to impede the market growth over the forecast period.
Europe Advanced Wound Care Market Trends
Foam Dressings Sub-segment is Projected to Register Significant Growth Over the Forevast
Foam dressing is a highly absorbent dressing used for wound care. Compared to other types of dressings, foam dressings need less changing. The advantage of foam dressings is that they help maintain a moist wound environment. Also, the foam helps cushion the wound and peri-wound area from additional trauma and provides thermal insulation for wounds.
The significant prevalence of diabetic patients is anticipated to boost the demand for foam dressings. For instance, an article published in the Journal of Clinical Pathology in October 2023 mentioned individuals with diabetes are 25% more likely to develop foot ulcers and chronic wounds. Thus, it is anticipated that as diabetes rates rise, the number of ulcer cases requiring advanced wound care will also increase, contributing to the studied segment growth.
In addition, various sources have suggested many advantages of foam dressings, such as covering the wound bed with foam dressing, which encourages more rapid spontaneous healing of soft tissue injuries. By covering the border of the wound and preventing bacterial development in the damaged area, the foam dressing lowers the risk of infection and inflammation. Hence, owing to the advantages of foam dressings, the market is expected to grow significantly over the forecast period.
Moreover, in April 2024, Smith+Nephew, headquartered in the United Kingdom, published data for its ALLEVYN LIFE Foam Dressing study in the International Wound Journal. The study showed a novel mechanism of action relating to pressure injury prevention (PIP). Hence, such initiatives are expected to increase segment growth by increasing the availability of foam dressing products over the coming years.
Therefore, owing to the above-mentioned factors such as significant advantages and applications of foam dressings and rising research studies for the development of advanced foam dressing, are likely to fuel the studied market growth in the region.
Understand The Key Trends Shaping This Market
Download PDF
France is Expected to Have Significant Growth in the Market Over the Forecast Period
France is expected to be the fastest-growing country in the market studied and is predicted to continue its growth trend over the next few years. The rising incidence of chronic diseases such as diabetes, obesity, and conditions contributes to an increased demand for wound care products in the France market.
The increasing incidences of diabetes further lead to growth in this market as diabetic patients are at increased risk of diabetic foot ulcers. For instance, according to the data published by the International Diabetes Federation in 2024, about 4.23 million patients are estimated to live with diabetes in France by 2045. Hence, a high number of the diabetic population indicates the chances of a rise in diabetes-related ulcers or wounds, which is believed to propel the growth France's advanced wound care market.
Furthermore, significant clinical studies on advanced wound care products in France are another factor in market growth. For instance, in an article published in the Journal of Clinical Medicine in August 2023, the researchers in France mentioned that the evaluation of chronic wounds and the development of effective medical devices and pharmaceuticals for wound care depend significantly on a thorough understanding of the wound microenvironment. Additionally, the same source reported that researchers are focused on exploring interactive, bioactive, and smart wound dressings as potential treatments for chronic wounds with various underlying causes. Hence, due to the abovementioned factors, the market is likely to increase the need for advanced wound care products and boost the market growth in the country.
Get Analysis on Important Geographic Markets
Download PDF
Europe Advanced Wound Care Industry Overview
The advanced wound care market is significantly fragmented, with the presence of a large number of players. As technology progresses and becomes more viable, the quality of life of patients afflicted with chronic wounds improves. Market players are focusing on various growth strategies, in order to enhance the market presence by mergers, acquisitions, partnerships, collaborations, new product launches, etc. The major players that currently dominate the market include Coloplast AS, Integra Lifesciences, Convatec Group PLC, Smith + Nephew and Paul Hartmann AG.
Europe Advanced Wound Care Market Leaders
-
Coloplast AS
-
ConvaTec Group PLC
-
Smith & Nephew
-
Integra Lifesciences
-
Paul Hartmann AG
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Europe Advanced Wound Care Market News
- July 2024: Sonoma Pharmaceuticals, Inc. bolstered its European distributor network by partnering with Smart Healthcare Company (SHC) s.r.o., facilitating the distribution of its Microdacyn60 wound care products in Ukraine.
- May 2024: Convatec in London unveiled the results of a multinational randomized controlled trial (RCT). The study highlights significant advancements in healing venous leg ulcers using AQUACEL Ag+ Extra, outpacing the standard care dressing.
Europe Advanced Wound Care Industry Segmentation
As per the scope of the report, advanced wound care comprises products for acute and chronic wounds, such as ulcers, burns, and post-operative wounds. Advanced wound care products, such as film and foam dressings, hydrogels, alginates, and hydrocolloids, keep the wound hydrated for healing without occluding the wound.
The advanced wound care market in Europe is segmented by product, wound type, and geography. By product, the market is segmented into wound dressings, active wound care, therapy devices, and other advanced wound care products. The wound dressings include film dressings, foam dressings, hydrogel dressings, collagen dressings, and other dressings. The active wound care includes skin substitutes and growth factors. The therapy devices include negative pressure wound therapy, pressure relief devices, hyperbaric oxygen equipment, compression therapy, and other therapy devices. By wound type, the market is segmented into chronic wounds and acute wounds. Chronic wounds include diabetic foot ulcers, pressure ulcers, arterial and venous ulcers, and other chronic wounds. The acute wound includes surgical wounds, burns, and other acute wounds. By geography, the market is segmented into Germany, United Kingdom, France, Italy, Spain, Rest of Europe. The report offers the value (in USD) for the above segments.
| By Product | Wound Dressings | Film Dressings | |
| Foams Dressings | |||
| Hydrogel Dressings | |||
| Collagen Dressings | |||
| Other Dressings | |||
| Active Wound Care | Skin Substitutes | ||
| Growth Factors | |||
| Therapy Devices | Negative Pressure Wound Therapy | ||
| Pressure Relief Devices | |||
| Hyperbaric Oxygen Equipment | |||
| Compression Therapy | |||
| Other Therapy Devices | |||
| Other Advance Wound Care Products | |||
| By Wound Type | Chronic Wound | Diabetic Foot Ulcer | |
| Pressure Ulcer | |||
| Arterial and Venous Ulcer | |||
| Other Chronic Wound | |||
| Acute Wound | Surgical Wounds | ||
| Burns | |||
| Other Acute Wounds | |||
| Geography | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
Need A Different Region or Segment?
Customize Now
Europe Advanced Wound Care Market Research FAQs
How big is the Europe Advanced Wound Care Market?
The Europe Advanced Wound Care Market size is expected to reach USD 4.22 billion in 2025 and grow at a CAGR of 6.10% to reach USD 5.68 billion by 2030.
What is the current Europe Advanced Wound Care Market size?
In 2025, the Europe Advanced Wound Care Market size is expected to reach USD 4.22 billion.
Who are the key players in Europe Advanced Wound Care Market?
Coloplast AS, ConvaTec Group PLC, Smith & Nephew, Integra Lifesciences and Paul Hartmann AG are the major companies operating in the Europe Advanced Wound Care Market.
What years does this Europe Advanced Wound Care Market cover, and what was the market size in 2024?
In 2024, the Europe Advanced Wound Care Market size was estimated at USD 3.96 billion. The report covers the Europe Advanced Wound Care Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Europe Advanced Wound Care Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Europe Advanced Wound Care Industry Report
Statistics for the 2025 Europe Advanced Wound Care market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Advanced Wound Care analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
